BioSig Technologies, Inc. (BSGM) financial statements (2023 and earlier)
Company profile
Business Address |
55 GREENS FARMS ROAD WESTPORT, CT 06880 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 11,700 | 17,535 | 15,504 | 22,475 | 28,268 | 32,748 | 36,927 | ||
Cash and cash equivalents | 11,700 | 17,535 | 15,504 | 22,475 | 28,268 | 32,748 | 36,927 | ||
Receivables | 100 | 199 | |||||||
Inventory, net of allowances, customer advances and progress billings | 1,881 | 1,881 | 731 | 650 | 768 | 806 | 800 | ||
Inventory | 1,881 | 1,881 | 731 | 650 | 768 | 806 | 800 | ||
Prepaid expense | 354 | 433 | 515 | 209 | 301 | 338 | 454 | ||
Other current assets | 433 | 515 | 209 | 301 | |||||
Other undisclosed current assets | (41) | (383) | (515) | (209) | (301) | 471 | |||
Total current assets: | 13,894 | 19,999 | 16,949 | 23,334 | 29,337 | 33,893 | 38,652 | ||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 604 | 693 | 252 | 356 | 306 | 410 | 513 | ||
Property, plant and equipment | 652 | 557 | 388 | 381 | 289 | 188 | 175 | ||
Intangible assets, net (including goodwill) | 327 | 332 | 337 | 342 | 347 | 351 | 356 | ||
Intangible assets, net (excluding goodwill) | 327 | 332 | 337 | 342 | 347 | 351 | 356 | ||
Prepaid expense | 1 | 5 | 10 | 14 | |||||
Deposits noncurrent assets | 42 | 92 | 101 | 102 | 102 | 102 | 102 | ||
Other noncurrent assets | 424 | 438 | |||||||
Other undisclosed noncurrent assets | (424) | (438) | (0) | 0 | |||||
Total noncurrent assets: | 1,625 | 1,674 | 1,078 | 1,182 | 1,049 | 1,061 | 1,160 | ||
TOTAL ASSETS: | 15,519 | 21,673 | 18,027 | 24,516 | 30,386 | 34,953 | 39,812 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 2,179 | 2,169 | 3,027 | 3,459 | |||||
Accrued liabilities | 243 | 280 | 332 | 312 | |||||
Employee-related liabilities | 552 | 499 | 515 | 448 | |||||
Interest and dividends payable | 82 | 79 | 77 | 75 | |||||
Settlement liabilities | 613 | 1,000 | 13 | 13 | |||||
Other undisclosed accounts payable and accrued liabilities | 689 | 311 | 2,090 | 2,610 | |||||
Deferred revenue | 32 | 32 | 32 | 32 | |||||
Due to related parties | 86 | 80 | 80 | 147 | 317 | 155 | 98 | ||
Other undisclosed current liabilities | 279 | 290 | 244 | 258 | 4,791 | 4,805 | 3,509 | ||
Total current liabilities: | 2,576 | 2,571 | 3,383 | 3,896 | 5,108 | 4,960 | 3,607 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 373 | 409 | 1 | 28 | 1 | 22 | 89 | ||
Operating lease, liability | 373 | 409 | 1 | 28 | 1 | 22 | 89 | ||
Liabilities, other than long-term debt | 5 | 13 | 21 | 29 | |||||
Deferred revenue | 5 | 13 | 21 | 29 | |||||
Other undisclosed noncurrent liabilities | (1) | 5,108 | 4,937 | 3,518 | |||||
Total noncurrent liabilities: | 378 | 422 | 22 | 57 | 5,109 | 4,982 | 3,695 | ||
Other undisclosed liabilities | (5,108) | (4,960) | (3,607) | ||||||
Total liabilities: | 2,954 | 2,993 | 3,405 | 3,953 | 5,109 | 4,982 | 3,695 | ||
Temporary equity, carrying amount | 105 | 105 | 105 | 105 | 105 | 105 | 105 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | 12,241 | 18,137 | 14,143 | 19,876 | 24,370 | 28,546 | 33,218 | ||
Common stock | 36 | 35 | 32 | 32 | 31 | 30 | 29 | ||
Additional paid in capital | 201,127 | 198,380 | 187,136 | 185,168 | 181,344 | 175,228 | 168,499 | ||
Accumulated deficit | (188,922) | (180,278) | (173,025) | (165,324) | (157,005) | (146,712) | (135,311) | ||
Stockholders' equity attributable to noncontrolling interest | 219 | 438 | 374 | 582 | 802 | 1,320 | 2,794 | ||
Other undisclosed stockholders' equity | (0) | (0) | |||||||
Total stockholders' equity: | 12,460 | 18,575 | 14,517 | 20,458 | 25,172 | 29,866 | 36,012 | ||
TOTAL LIABILITIES AND EQUITY: | 15,519 | 21,673 | 18,027 | 24,516 | 30,386 | 34,953 | 39,812 |
Income statement (P&L) ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 8 | 108 | 207 | 118 | ||||
Cost of revenue | (38) | (62) | (99) | |||||
Gross profit: | 8 | 70 | 145 | 19 | ||||
Operating expenses | (9,007) | (7,871) | (8,196) | (8,579) | (10,932) | (13,100) | (22,349) | |
Other undisclosed operating loss | (1) | (0) | ||||||
Operating loss: | (8,999) | (7,801) | (8,051) | (8,560) | (10,932) | (13,100) | (22,349) | |
Nonoperating income (expense) | 1 | (44) | 2 | 2 | ||||
Investment income, nonoperating | (44) | 2 | 2 | |||||
Other nonoperating income | 1 | |||||||
Interest and debt expense | 553 | |||||||
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (2) | 1 | 44 | |||||
Loss from continuing operations before equity method investments, income taxes: | (9,001) | (7,247) | (8,051) | (8,559) | (10,932) | (13,098) | (22,346) | |
Other undisclosed income from continuing operations before income taxes | 2 | |||||||
Loss from continuing operations before income taxes: | (8,999) | (7,247) | (8,051) | (8,559) | (10,932) | (13,098) | (22,346) | |
Other undisclosed income (loss) from continuing operations | 555 | (554) | (0) | (0) | (2) | (2) | ||
Loss before gain (loss) on sale of properties: | (8,444) | (7,801) | (8,051) | (8,559) | (10,932) | (13,100) | (22,349) | |
Other undisclosed net income (loss) | (555) | 554 | 0 | 0 | 2 | 2 | ||
Net loss: | (8,999) | (7,247) | (8,051) | (8,559) | (10,932) | (13,098) | (22,346) | |
Net income (loss) attributable to noncontrolling interest | 355 | (6) | 350 | 239 | 639 | 1,697 | 3,158 | |
Other undisclosed net income attributable to parent | 1 | 0 | ||||||
Net loss attributable to parent: | (8,644) | (7,253) | (7,701) | (8,319) | (10,292) | (11,402) | (19,188) | |
Other undisclosed net loss available to common stockholders, basic | (2) | (2) | (3) | (2) | (2) | (2) | (5) | |
Net loss available to common stockholders, diluted: | (8,646) | (7,255) | (7,704) | (8,321) | (10,295) | (11,404) | (19,193) |
Comprehensive Income ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (8,999) | (7,247) | (8,051) | (8,559) | (10,932) | (13,098) | (22,346) | |
Comprehensive loss: | (8,999) | (7,247) | (8,051) | (8,559) | (10,932) | (13,098) | (22,346) | |
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 355 | (6) | 350 | 239 | 639 | 1,697 | 3,158 | |
Comprehensive loss, net of tax, attributable to parent: | (8,644) | (7,253) | (7,701) | (8,320) | (10,293) | (11,402) | (19,188) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.